Source: Benzinga

Johnson & Johnson: Johnson & Johnson, Protagonist Tout Positive Results For Psoriasis Oral Pill Study

Protagonist and Johnson & Johnson report positive Phase 3 data on icotrokinra in adolescent plaque psoriasis, showing high clearance rates and favorable safety. read more

Read full article »

Johnson & Johnson's Competitors | Johnson & Johnson's News | Johnson & Johnson's Financials

Followers on Owler

38,941

Annual Revenue

$50-100B

Employees

100K-9.9M

Chairman & CEO

Joaquin Duato

CEO Approval Rating

62/100

Johnson & Johnson is a New Jersey-based firm that engages in research, manufacturing and sale of healthcare products including consumer, pharmaceutical and medical devices.